Showing results (151-160 of 252) with videos related to
Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry|January 31, 2009
Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agentsKatherine J Kayser-Bricker, Matthew P Glenn, Sang Hoon Lee, et al.Organic & Biomolecular Chemistry|June 10, 2006
Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylationHuchen Zhou, De-an Wang, Laura Baldini, et al.Journal of Medicinal Chemistry|January 5, 2002
Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffoldJunko Ohkanda, Jeffrey W Lockman, Mohit A Kothare, et al.RSC Chemical Biology|August 30, 2021
Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agentsDebabrata Maity, Sunil Kumar, Ruyof AlHussein, et al.Organic & Biomolecular Chemistry|April 25, 2006
Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-IHairuo Peng, Dora Carrico, Van Thai, et al.Biochemistry|April 2, 2026
Prion Protein-Derived Cell-Penetrating Peptide Inhibits Type II Diabetes-Associated Islet Amyloid Polypeptide Aggregation and CytotoxicityYujeong Oh, L Palanikumar, Madeline Howarth, et al.Tetrahedron Letters|June 10, 2014
Baeyer-Villiger Rearrangement of a Substituted Pyrrole by OxoneJoseph P Y Kao, Sukumaran Muralidharan, Peter Y Zavalij, et al.RSC Medicinal Chemistry|April 27, 2026
Lead optimization of <b>5jc21</b> (CG13250), a quinolin-2(1<i>H</i>)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteinsJay Chauhan, Sarah Pogash, Makoto Yoshioka, et al.Pharmaceutical Research|March 19, 2026
Evaluation of Mass Spectrometry Compatible Reagents for Determining Small Molecule Loading in Poly(lactic acid) NanoparticlesSamuel A Krug, Andrea L Cottingham, Masahiro Iwamoto, et al.ACS Pharmacology & Translational Science|November 21, 2022
Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory ChallengeNhu Truong, Christopher C Goodis, Andrea L Cottingham, et al.Pageof 26